Q4 2022 Acorda Therapeutics Inc Earnings Call Transcript

Mar 09, 2023 / 01:30PM GMT
Operator

Welcome to the Acorda Therapeutics Fourth Quarter and Year-End 2022 Financial and Business Update. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

I will now introduce your host for today's call, Tierney Saccavino, at Acorda. Tierney, please go ahead.

Tierney Saccavino - Acorda Therapeutics, Inc. - EVP of Corporate Communications

Thank you, Emily, and good morning, everyone. So before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to refer to those filings. Today, during the Q&A, we will first take calls from our analysts, and then we will take questions that other investors have written in when they have registered for the call.

I'll now pass the call over to our CEO, Ron Cohen. Ron?

Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director

Thanks, Tierney. Good morning, everyone. Diving

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot